These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1078 related items for PubMed ID: 15006018

  • 1. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R.
    Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E, FitzGerald JM.
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [Abstract] [Full Text] [Related]

  • 13. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
    Price DB, Williams AE, Yoxall S.
    Respir Res; 2007 Jul 04; 8(1):46. PubMed ID: 17610727
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.
    Pharmacoeconomics; 2006 Jul 04; 24(7):695-708. PubMed ID: 16802845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
    Price D, Wirén A, Kuna P.
    Allergy; 2007 Oct 04; 62(10):1189-98. PubMed ID: 17845590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.